Biotech
Zymergen
Zymergen raises $130M Series C at $560M valuation
Emeryville, CADecember 4, 20181 min read
Total Raised
$130M
Valuation
$560M
Latest Round
Series C
Employees
500+
Zymergen: Series C Funding Round
Zymergen has successfully raised $130M in Series C funding, reaching a valuation of $560M.
Company Overview
Bio-based materials and molecule development
Funding Details
The Series C round was led by SoftBank Vision Fund, with participation from Data Collective.
Company Information
- Headquarters: Emeryville, CA
- Founded: 2013
- Employees: 500+
- Category: Biotech
Investment
Zymergen plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- SoftBank Vision Fund: Verified investor in Series C
- Data Collective: Verified investor in Series C
Company Info
Headquarters
Emeryville, CA
Founded
2013
Team Size
500+
Last Round
$130M(Dec 2018)
Investors (2)
S
SoftBank Vision FundLeadLead Investor
Verified investor in Series C
D
Data CollectiveInvestor
Verified investor in Series C
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free